U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 14

6

U . S . IN VITRO DIAGNOSTICS MARKET , BY PRODUCT & SERVICE ........................................... 43

• 6.1

INTRODUCTION ............................................................................................................................................................... 44

• 6.2

REAGENTS ....................................................................................................................................................................... 46

• 6.3

INSTRUMENTS ................................................................................................................................................................. 47

• 6.3.1

FULLY AUTOMATED INSTRUMENTS ............................................................................................................. 48

• 6.3.2

SEMI-AUTOMATED INSTRUMENTS .............................................................................................................. 49

• 6.3.3

OTHERS ......................................................................................................................................................... 49

• 6.4

DATA MANAGEMENT SOFTWARE .................................................................................................................................... 50

• 6.5

SERVICES ......................................................................................................................................................................... 51

7

U . S . IN VITRO DIAGNOSTICS MARKET , BY TECHNOLOGY ....................................................... 52

• 7.1

INTRODUCTION ............................................................................................................................................................... 53

• 7.2

CLINICAL CHEMISTRY .................................................................................................................................................... 54

• 7.3

IMMUNOCHEMISTRY / IMMUNOASSAYS ......................................................................................................................... 55

• 7.4

MICROBIOLOGY ............................................................................................................................................................... 56

• 7.5

MOLECULAR DIAGNOSTICS ( MDX )................................................................................................................................ 57

• 7.6

HEMATOLOGY .................................................................................................................................................................. 58

• 7.7

COAGULATION / HEMOSTASIS .......................................................................................................................................... 59

• 7.8

OTHER IVD TECHNOLOGIES ............................................................................................................................................ 60

8

U . S . IN VITRO DIAGNOSTICS MARKET , BY APPLICATION ........................................................ 61

• 8.1

INTRODUCTION ............................................................................................................................................................... 62

• 8.2

INFECTIOUS DISEASES ................................................................................................................................................... 63

• 8.3

DIABETES ......................................................................................................................................................................... 65

• 8.4

ONCOLOGY / CANCER ....................................................................................................................................................... 66

• 8.5

CARDIOVASCULAR DISORDERS ..................................................................................................................................... 67

• 8.6

ENDOCRINE DISORDERS ................................................................................................................................................. 68

• 8.7

AUTOIMMUNE DISEASES ................................................................................................................................................ 70

• 8.8

BONE & MINERAL-RELATED DISEASES .......................................................................................................................... 71

• 8.9

PULMONARY DISEASES .................................................................................................................................................. 72

• 8.10

OTHER APPLICATIONS .................................................................................................................................................... 73

•